Full name
NEUROEXPANDER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
18.20.Z - Reproduction of recorded media
46.19.Z - Agents involved in the sale of a variety of goods
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
62.03.Z - Computer facilities management activities
63.11.Z - Data processing, hosting and related activities
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
96.04.Z - Physical well-being activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,1 | -0 | -150,4 |
EBITDA | 0,2 | 0,1 | -0 | -120,8 |
Short time liabilities | 0,8 | 0,3 | 0,4 | 6,4 |
Equity capital | 0,9 | 1,1 | 1,1 | -3,1 |
Operating profit (EBIT) | 0,2 | 0,1 | -0 | -120,8 |
Assets | 1,8 | 1,6 | 1,5 | -0,9 |
Net profit (loss) | 0,2 | 0,1 | -0 | -155,7 |
Cash | 0,1 | 0,3 | 0,2 | -8,8 |
Net income from sale | 0,7 | 0,6 | 0,1 | -78,2 |
Liabilities and provisions for liabilities | 0,9 | 0,4 | 0,4 | 5,1 |
Working assets | 1,5 | 1,1 | 1,1 | 1,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 22,9 | 5,5 | -3,2 | -8,7 |
Equity capital to total assets | 48,3 | 73,3 | 71,7 | -1,6 |
Gross profit margin | 31,5 | 11,8 | -27,2 | -39 |
EBITDA Margin | 32,7 | 14,8 | -14,1 | -28,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 445 | 206 | 1004 | 798 |
Current financial liquidity indicator | 1.6564037799835205 | 2.972808837890625 | 2.850273847579956 | -0,1 |
Net dept to EBITDA | -0.1323169469833374 | -0.9338338375091553 | 1.6192630529403687 | 2,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane